ANXA5 and breast cancer: To investigate whether combined EZH2/ATM inhibition induces apoptosis in BRCA1-deficient mouse mammary tumor cells, we measured the percentage of Annexin V/propidium iodide double-positive cells by flow-cytometry (Fig. 3D).